FY2028 Earnings Estimate for AXSM Issued By Leerink Partnrs
Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) – Equities researchers at Leerink Partnrs cut their FY2028 earnings per share (EPS) estimates for Axsome Therapeutics in a report issued on Friday, February 21st. Leerink Partnrs analyst M. Goodman now forecasts that the company will post earnings of $9.30 per share for the year, down from their […]
